Menu

Press Statements

Sanofi Response to Public Citizen

Oct 28, 2016

Sanofi is committed to the development of innovative medicines and vaccines to prevent and treat important medical conditions around the world. Our objective is to ensure patients have access to our products, balancing clinical value and affordability while making continued investments in innovation. Any focus on accessibility of medicines in the US should involve all relevant stakeholders who contribute to cost and value across the healthcare system – from the time a product is discovered to when it ultimately reaches the patient.